American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
NCT01066208 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3588
Last updated 2016-08-19
Summary
Vasculitis is group of diseases where inflammation of blood vessels is the common feature. Patients typically present with fever, fatigue, weakness and muscle and joint aches. These symptoms are very common among many different diseases, not just vasculitis. A clustering of other symptoms, physical examination findings, blood tests, radiology and biopsy help make the diagnosis. There are currently no criteria to help doctors make a diagnosis of vasculitis when a patient presents with these non specific symptoms and they are reliant on previous experience and disease definitions. One of the aims of this project is to develop diagnostic criteria for the primary systemic vasculitides (granulomatosis with polyangiitis (Wegener's), microscopic polyangiitis, Churg Strauss syndrome, polyarteritis nodosa, giant cell arteritis, Takayasu arteritis). We, the investigators, will do this by studying a large group of patients with vasculitis and comparing them to a large group of patients that present in a similar way, but do not have vasculitis. By comparing the 2 groups we will create a list of items to differentiate between vasculitis and 'vasculitis mimics'.
We also aim to update the current classification criteria. Classification criteria are used to group patients into different types of vasculitis, once a diagnosis of vasculitis has been made, and are useful for studying patients in clinical trials with similar or identical diseases. The current classification criteria (American college of Rheumatology 1990 criteria) were developed 20 years ago, before the availability of some important diagnostic tests (e.g. antineutrophil cytoplasmic antibodies \[ANCA\]), and are now not consistent with some of the current disease definitions. Therefore to progress future research in vasculitis, it is important that the classification criteria are updated. We will recruit 260 patients with each of the 6 types of vasculitis and compare them with 1300 controls (patients with the 5 other types of vasculitis), in order to determine the optimal combination of symptoms, signs and investigations that classify each person into the appropriate group.
Conditions
- Wegener's Granulomatosis
- Microscopic Polyangiitis
- Churg Strauss Syndrome
- Polyarteritis Nodosa
- Giant Cell Arteritis
- Takayasu Arteritis
Sponsors & Collaborators
-
American College of Rheumatology
collaborator OTHER -
The European League Against Rheumatism (EULAR)
collaborator UNKNOWN -
The Vasculitis foundation
collaborator UNKNOWN -
University of Oxford
lead OTHER
Principal Investigators
-
Raashid A Luqmani, DM, FRCP(E) · University of Oxford, United Kingdom
-
Peter Merkel, MD, MPH · University of Pennsylvania
-
Richard Watts, DM, FRCP · University of East Anglia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-12-31
Countries
- United States
- Argentina
- Australia
- Austria
- Belgium
- Canada
- China
- Czechia
- Denmark
- Egypt
- Finland
- France
- Germany
- Hungary
- India
- Ireland
- Italy
- Japan
- Mexico
- Netherlands
- New Zealand
- Norway
- Poland
- Portugal
- Russia
- Slovenia
- South Korea
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
NCT01402661 ·Status: ENROLLING_BY_INVITATION
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis
NCT03843619 ·Status: UNKNOWN
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Rheumatology Clinical Registry
NCT01813409 ·Status: UNKNOWN
-
Uromodulin in Rheumatoid Arthritis
NCT03972098 ·Status: COMPLETED
-
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00242853 ·Status: COMPLETED
-
Reduced Ultrasound Counts in Rheumatoid Arthritis
NCT02389283 ·Status: UNKNOWN
-
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001375 ·Status: COMPLETED
-
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
NCT02109289 ·Status: TERMINATED ·Phase: PHASE4
-
Diagnostic Criteria for Septic Arthritis
NCT05790434 ·Status: UNKNOWN
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Genetic Registry for Rheumatoid Arthritis
NCT00069472 ·Status: COMPLETED
-
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
NCT02874092 ·Status: COMPLETED ·Phase: PHASE4
-
Remission Induction in Very Early Rheumatoid Arthritis
NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
NCT04102930 ·Status: RECRUITING
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic Arthritis
NCT06024486 ·Status: NOT_YET_RECRUITING
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Sensitivity of Echography in Arthritis
NCT00444691 ·Status: UNKNOWN ·Phase: NA